Table II.
Genes associated with FTLD and ALS.
Gene | Locus | Inheritance | Mutation type | Mutation frequency FTLD | Mutation frequency ALS | Molecular pathology | Comment |
---|---|---|---|---|---|---|---|
MAPT (94) | 17q21 | AD | Missense, splice site, deletion | 5%–10% | – | Tau | |
PGRN (92,93) | 17q21 | AD | Nonsense, splice site, frameshift, deletion, met1, missense | 5%–10% | – | TDP-43 | FTLD-TDP type A |
VCP (105) | 9p13 | AD | Missense | < 1% | < 1% | TDP-43 | In combination with IBM and PDB; FTLD-TDP type D |
CHMP2B (100) | 3p11 | AD | Nonsense | < 1% | – | UPS | |
TMEM106B (131) | 7p21 | Risk factor | / | / | / | TDP-43 | |
C9orf72 (132–134) | 9p21 | AD | GGGGCC expansion | 5%–10%? | 5%–10%? | TDP-43, UPS | FTLD-TDP type B? |
SOD1 (106) | 21q22 | AD and AR | Missense, frameshift nonsense | – | ∼5% | SOD1 | |
TARDBP (110,111) | 1p36 | AD | Missense, nonsense | < 1% | ∼1% | TDP-43 | |
FUS (65,66) | 16q12 | AD and AR | Missense, nonsense, splice site, frameshift | < 1% | ∼1% | FUS | Also associated with juvenile ALS with BIBD |
ATXN2 (112) | 12q24 | AD and risk factor | GAG expansion | – | ∼1% | TDP-43 | Intermediate expanded alleles cause ALS, longer alleles cause SCA2 |
ANG (115) | 14q11 | AD and risk factor | Missense | – | < 1% | TDP-43 | |
OPTN (117) | 10p13 | AD and AR | Missense, exon-deletion nonsense | – | < 1% | TDP-43 | |
VAPB (116) | 20q13 | AD | Missense | – | < 1% | ? | Classic ALS, slow-progressive ALS, late onset SMA |
UBQLN2 (118) | Xp11 | AD | Missense | < 1% | < 1% | TDP-43 |
Sub-classification of FTLD-TDP is according to (135).
AD = autosomal dominant; AR = autosomal recessive; BIBD = basophilic inclusion body disease; IBM = inclusion body myositis; met1 = mutation of Met1 translation initiation codon; PDB = Paget's disease of the bone; SCA2 = spinocerebellar ataxia type 2; SMA = spinal muscular atrophy.